FUTURE OF HEALTHCARE

DispatchHealth Raises More Than $330 Million to Expand Its Technology-Enabled Ecosystem of High Acuity Care in the Home

DispatchHealth | November 24, 2022 | Read time : 04:00 min

DispatchHealth Raises

DispatchHealth, the nation's first comprehensive in-home, high acuity medical care provider announced it has raised more than $330 million in combined equity and debt financing. The equity round of $259 million was led by Optum Ventures, with participation from new investors Adams Street Partners, Blue Shield of California, among others, and continued support from existing investors Humana, Echo Health Ventures, Questa Capital and Oak HC/FT. K2 HealthVentures, Silicon Valley Bank and SVB Capital provided debt financing of $75 million, with up to an additional $75 million available for growth initiatives, bringing the total raised to more than $400 million.

In the United States, $4 trillion is spent on healthcare annually and it is projected to exceed $6 trillion by 2028. With more than a third of this spend on care delivered in traditional brick-and-mortar facilities, the healthcare industry has reached a watershed moment. DispatchHealth's in-home, high acuity care model aligns health plans, health systems, at-risk provider groups and patients with complex care needs by delivering a value-based alternative to high-cost settings such as the emergency room, hospital ward or skilled nursing facility, reducing medical costs while improving clinical outcomes and patient and provider satisfaction.

"For the past seven years, we have been building a comprehensive ecosystem of high acuity care in the home. Our proven approach to delivering healthcare to complex patients in their homes will continue to transform healthcare. This round of funding is a testament to what we and our passionate team members have created at DispatchHealth and the belief our partners have in our leading-edge care model."

Dr. Mark Prather, Co-Founder and CEO of DispatchHealth

Today, DispatchHealth provides high acuity care to complex patients across 34 states and has developed innovative relationships with health plans, provider groups, health systems, employers, senior living facilities, and home health organizations to deliver a better, more coordinated healthcare experience. DispatchHealth is also one of the largest and most experienced providers of Advanced Care, a hospital alternative, and Extended Care, a skilled nursing facility alternative. To coordinate the complex ecosystem of in-home care, DispatchHealth has created an operating system for high acuity care in the home. The proprietary technology platform uses real-time data insights to manage all aspects of the in-home care experience, including logistics, onboarding, risk stratification, care coordination and analytics that elevate the clinical practice and drive improved outcomes.

DispatchHealth will use the financing to

  • Expand its proven in-home high acuity care ecosystem in existing markets and key expansion markets;
  • Accelerate its technology platform development to deliver consistent and scalable patient-centric care; and,
  • Strategically grow its portfolio of in-home system of care and last mile care capabilities.

"DispatchHealth is transforming the healthcare industry by improving access to outcomes-driven, high-quality, in-home care and delivering on the enhanced experience patients deserve.  Optum Ventures is honored to deepen our relationship with DispatchHealth and its experienced leadership team as they continue to expand their reach of high acuity, in-home care to serve patients with complex care needs across the nation," said Laura Veroneau, Managing Partner at Optum Ventures. 

"DispatchHealth's comprehensive and unique ecosystem of in-home care is compelling. Adams Street is thrilled to support DispatchHealth as they expand their system of care, particularly their high acuity hospitalization substitution model. We believe DispatchHealth is positioned to catalyze important and necessary advances in the healthcare industry," said Tom Bremner, a Partner at Adams Street Partners.

About DispatchHealth  
DispatchHealth brings the power of the hospital to the comfort of the home. DispatchHealth is building the leading in-home system of care and offers on-demand acute care and an advanced level of medical care for people of all ages in the comfort of their own homes. DispatchHealth's emergency medicine and internal medicine trained medical teams are equipped with all the tools necessary to treat common to complex injuries and illnesses. DispatchHealth works closely with payers, providers, health systems, EMS, employer groups and others to deliver care in the home to reduce unnecessary emergency room visits, hospital stays and readmissions. Acute Care medical teams are available seven days a week, evenings and holidays and can be requested online or via a quick phone call. DispatchHealth is partnered with most major insurance companies. 

About Optum Ventures
Optum Ventures is the independent venture fund of UnitedHealth Group. Optum Ventures invests in digital health companies that use data and insights to help improve consumers' access to healthcare services and how care is delivered and paid for, and that make the health care system more reliable and easier to navigate. 

About Adams Street Partners
Adams Street Partners is a global private markets investment manager with investments in more than thirty countries across five continents. The firm is 100% employee-owned and has $50 billion in assets under management. Adams Street strives to generate actionable investment insights across market cycles by drawing on 50 years of private markets experience, proprietary intelligence, and trusted relationships. Adams Street has offices in Austin, Beijing, Boston, Chicago, London, Menlo Park, Munich, New York, Seoul, Singapore, and Tokyo.

Spotlight

Private, not-for-profit, integrated health care provider. 30 counties, 90 communities, 15 hospitals. More than 150 clinics, 70 pharmacies,  32,000 caregivers – including 1,800 employed physicians.  Largest home care organization in Wisconsin.  More than 1.2 million unique patients, 8.8 million patient encounters,  $4.9 billion in annual revenue (2015).

Spotlight

Private, not-for-profit, integrated health care provider. 30 counties, 90 communities, 15 hospitals. More than 150 clinics, 70 pharmacies,  32,000 caregivers – including 1,800 employed physicians.  Largest home care organization in Wisconsin.  More than 1.2 million unique patients, 8.8 million patient encounters,  $4.9 billion in annual revenue (2015).

Related News

HEALTH TECHNOLOGY

GE Healthcare Announces $80 Million Investment To Expand Contrast Media Production Capacity

GE Healthcare | November 18, 2022

GE Healthcare’s Pharmaceutical Diagnostics business announced an $80 million investment to increase manufacturing capacity by 30 percent at its Active Pharmaceutical Ingredients site in Lindesnes, Norway. The investmentwhich is creating around 100 new jobs – is part of GE Healthcare’s broader commitment to address significant future global demand for iodinated contrast media, used in Xray and Computed Tomography procedures around the world to enhance visualization of organs, blood vessels and tissues across disease pathways. Iohexol and iodixanol API are used in over 100 million patient doses of GE iodinated contrast media annually, equivalent to three patient procedures every second. This new investment, coupled with the recent opening of a new production line at GE Healthcare’s Cork, Ireland, fill and finish facility, aims to enable the production of 30 million more patient doses per year by 2025. “We expect global demand for iodinated contrast media to double in the next 10 years, driven by global prevalence of chronic disorders and significant growth in CT procedures. This investment in capacity expansion at our Lindesnes facility is another example of how we, as an industry leader, are addressing this growing demand to meet the needs of our customers and their patients across the globe.” President & CEO of GE Healthcare Pharmaceutical Diagnostics, Kevin O’Neill The 100-acre Lindesnes site in southern Norway, has been operating since 1974 and employs 450 people, who use multiple chemical pharmaceutical processes to convert iodine into finished API. Recently, GE Healthcare announced a multi-year agreement with SQM, a Chile-based mining company, to secure increasing supply of iodine, the key ingredient in iodinated contrast media. GE Healthcare is the world’s leading supplier of contrast media, used to support patient imaging procedures in 130+ countries globally. All stages of its contrast media manufacturing, from development of Active Pharmaceutical Ingredient (API) to finished product, are managed entirely by GE Healthcare, adhering to current Good Manufacturing Practices. With over 4000 employees globally and seven manufacturing sites, the Pharmaceutical Diagnostics business also develops and supplies radiopharmaceuticals used to support diagnosis, monitoring and treatment selection across Neurology, Cardiology and Oncology clinical pathways. About GE Healthcare GE Healthcare is the $17.7 billion healthcare business of GE. As a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 48,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.

Read More

HEALTHTECH SECURITY, MEDICAL DEVICES

Triad HealthCare Network Harnesses Medication Data to Improve Outcomes for High-Risk Patients

DrFirst | December 14, 2022

Triad HealthCare Network, a provider-led accountable care organization and health technology pioneer DrFirst announced an initiative to improve medication adherence among high-risk patient populations across five counties in North Carolina. Fast access to prescription fill data will empower providers to identify patients with chronic conditions who may not be taking their medications as prescribed and intervene early to alleviate barriers to adherence that can lead to gaps in care, poor outcomes, and hospital readmissions. Every year, medication non-adherence due to factors such as cost, access, coverage status, dosage complexity, or concerns about side effects causes about 125,000 deaths. In addition to needless human suffering, it costs nearly $250 billion to the U.S. healthcare system. Giving providers access to up-to-date prescription fill data can lead to better adherence and shed light on other health-related issues, which creates an opportunity for providers to enhance patient care. "Since patients' medication records are typically fragmented across the care continuum, our clinicians are excited about DrFirst's ability to provide current, comprehensive, and easy-to-access medication history, which will enhance our ability to deliver the right care at the right time. This ability is especially important among patients at high risk of complications, such as those with diabetes or congestive heart failure. In addition, we will be able to further improve care coordination and prevent avoidable admissions and emergency visits due to medication issues." Hanna Park, PharmD, Executive Director of Value-based Performance at Triad HealthCare Network MedHx PRM is based on DrFirst's award-winning MedHx, which streamlines medication reconciliation workflows by providing the most accurate and clinically actionable medication history for individual patients at hospital admission and in the emergency department. For population risk management, MedHx PRM expands prescription fill data to a population of patients to enable risk stratification and easy identification of those who would benefit from early and targeted care interventions. Using clinical analytics, care managers can create panels of high-risk patients or import them from an electronic health record (EHR) system and then easily identify those who are not adhering to medication therapies. In particular, ACOs need access to timely and accurate data to ensure patients get appropriate care while avoiding unnecessary duplication of services and preventing medical errors. "For ACOs to deliver on their promise of coordinated patient care, they need to gather clinical data from multiple systems and structure it in a way that makes it useful for clinicians," said G. Cameron Deemer, president of DrFirst. "Triad HealthCare Network is the first ACO to use MedHx PRM to collect medication data from payers, prescription benefit managers, and EHRs. By pulling thousands of de-duplicated patient medication histories automatically and quickly—usually within hours rather than months—clinicians can meaningfully intervene with patients before they end up back in their local hospital's emergency department."  About Triad HealthCare Network Triad HealthCare Network is a provider-led accountable care organization located in Greensboro, North Carolina. It serves nearly 200,000 people in Alamance, Guilford, Randolph, Rockingham, and part of Forsyth counties. THN is sponsored by Cone Health and is governed and operated by a board of managers and a physician-led operating committee. We believe by working together, our network can provide the right care, at the right place, at the right time. About DrFirst Since 2000, DrFirst has pioneered healthcare technology solutions and consulting services that securely connect people at touchpoints of care to improve patient outcomes. We create unconventional solutions that solve care collaboration, medication management, price transparency, and adherence challenges faced in healthcare. We unite the Healthiverse—the interconnected healthcare universe—by providing our clients with real-time access to the information they need, exactly when and how they need it, so patients get the best care possible. DrFirst solutions are used by nearly 325,000 healthcare professionals, including 220,000 prescribers, 70,000 pharmacies, 300 EHRs and health information systems, and 1,500 hospitals in the U.S. and Canada.

Read More

FUTURE OF HEALTHCARE, MEDICAL DEVICES

Tandem Diabetes Care Successfully Acquires AMF Medical SA

Tandem Diabetes Care | January 24, 2023

On January 23, 2023, Tandem Diabetes Care, Inc., a company specializing in diabetes technology, announced that it had successfully finished acquiring AMF Medical SA, a Switzerland-based medical equipment manufacturer that created the Sigi Patch Pump. Sigi Patch Pump is a rechargeable, ergonomic patch pump intended to lower the strain of managing diabetes by utilizing pre-filled insulin cartridges. It is currently under development and is not available for retail purchase. John Sheridan, President and Chief Executive Officer of Tandem Diabetes Care, said, "AMF Medical's compelling technology aligns well with our strategic vision to include a patch pump in Tandem's portfolio of differentiated offerings." He adds, "In addition to this innovative technology, the talented AMF team joining our Tandem family shares our commitment to simplify diabetes management and brings decades of experience from the diabetes device, life sciences, and watch-making industries." (Source – Business Wire) For this transaction, Tandem Diabetes Care received legal counsel from Baker & McKenzie LLP and Bass, Berry & Sims PLC. AMF Medical relied on SVB Securities LLC as its sole financial advisor, while Homburger AG served as its exclusive legal advisor. About Tandem Diabetes Care Headquartered in San Diego (California), Tandem Diabetes Care, Inc. is a medical device company aiming to better the lives of people with diabetes through endless innovation and a novel customer experience. The company employs a fresh and user-centric approach when it comes to developing, designing, and commercializing products for those who need to use insulin. As a result, Tandem Diabetes Care is creating a positive difference by assisting in creating better outcomes for people affected by diabetes and their healthcare providers.

Read More